Compare VANI & VLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | VLN |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | Israel |
| Employees | N/A | 233 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.0M | 116.9M |
| IPO Year | 2014 | N/A |
| Metric | VANI | VLN |
|---|---|---|
| Price | $1.20 | $1.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.50 | $3.00 |
| AVG Volume (30 Days) | 151.4K | ★ 3.4M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,000,000.00 | N/A |
| Revenue This Year | N/A | $8.37 |
| Revenue Next Year | N/A | $16.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $1.10 |
| 52 Week High | $1.92 | $3.71 |
| Indicator | VANI | VLN |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 38.69 |
| Support Level | $1.13 | $1.70 |
| Resistance Level | $1.25 | $2.04 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 50.00 | 6.34 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.